Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by DeBattista, C. Articles by Schatzberg, A. F. Search for Related Content PubMed Citation Articles by DeBattista, C. Articles by Schatzberg, A. F. Neuroendocrinology Depression Other Somatic Therapy

Acute Antidepressant Effects of Intravenous Hydrocortisone and CRH in Depressed Patients: A Double-Blind, Placebo-Controlled Study

OBJECTIVE: The primary objective of this investigation was to examine the acute antidepressant effects of intravenous hydrocortisone and ovine corticotropin releasing hormone (CRH) infusions in patients with major depression. METHOD: Twenty-two patients who met DSM-III-R criteria for nonpsychotic major depression were randomly assigned to receive intravenously 1 mg/kg of ovine CRH, 15 mg of hydrocortisone, or saline under double-blind conditions on day 1. Standard depression rating scales were completed on day 1 before the study medications were administered and again the following day (day 2). RESULTS: Patients treated with hydrocortisone demonstrated a significantly greater reduction in total 21-item Hamilton Depression Rating Scale scores (mean reduction=8.4 points or 37%) than patients given ovine CRH (mean=1.2 points) or placebo (mean=1.3 points). CONCLUSIONS: Acute hydrocortisone infusion is associated with a rapid and robust reduction in depressive symptoms. The authors discuss the therapeutic implications of these findings.

This article has been cited by other articles:

				C. A. Zarate Jr, J. B. Singh, P. J. Carlson, N. E. Brutsche, R. Ameli, D. A. Luckenbaugh, D. S. Charney, and H. K. Manji A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression. Arch Gen Psychiatry, August 1, 2006; 63(8): 856 - 864. [Abstract] [Full Text] [PDF]

				C. M. Pariante The glucocorticoid receptor: part of the solution or part of the problem? J Psychopharmacol, July 1, 2006; 20(4 Suppl): 79 - 84. [Abstract] [PDF]

				C. DeBattista Augmentation and combination strategies for depression. J Psychopharmacol, May 1, 2006; 20(3 Suppl): 11 - 18. [Abstract] [PDF]

				A. Kier, J. Han, and L. Jacobson Chronic Treatment with the Monoamine Oxidase Inhibitor Phenelzine Increases Hypothalamic-Pituitary-Adrenocortical Activity in Male C57BL/6 Mice: Relevance to Atypical Depression Endocrinology, March 1, 2005; 146(3): 1338 - 1347. [Abstract] [Full Text] [PDF]

				U. Voderholzer, F. Hohagen, T. Klein, J. Jungnickel, C. Kirschbaum, M. Berger, and D. Riemann Impact of Sleep Deprivation and Subsequent Recovery Sleep on Cortisol in Unmedicated Depressed Patients Am J Psychiatry, August 1, 2004; 161(8): 1404 - 1410. [Abstract] [Full Text] [PDF]

				S. L. King and K. M. Hegadoren Stress Hormones: How Do They Measure Up? Biol Res Nurs, October 1, 2002; 4(2): 92 - 103. [Abstract] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2000 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us